Skip to main content

Articles

Page 2 of 53

  1. The poor prognosis of advanced HCC and limited efficacy of current systemic treatments emphasize the need for new or combined targeted therapies. The development of HCC is a multistage process in which liver i...

    Authors: Astrid Vandierendonck, Helena Degroote, Bart Vanderborght, Xavier Verhelst, Anja Geerts, Lindsey Devisscher and Hans Van Vlierberghe

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:40

    Content type: Research

    Published on:

  2. Radiotherapy resistance is a major obstacle in the treatment of oesophageal squamous cell carcinoma (OSCC). Hypoxia is a critical cause of radioresistance. However, the communication between hypoxic cells and ...

    Authors: Fangyu Chen, Bing Xu, Jie Li, Xi Yang, Junjie Gu, Xijuan Yao and Xinchen Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:38

    Content type: Research

    Published on:

  3. The oncogenic activity of the high risk human papillomavirus type 16 (HPV16) is fully dependent on the E6 and E7 viral oncoproteins produced during viral infection. The oncoproteins interfere with cellular hom...

    Authors: Francesca Paolini, Carla Amici, Mariantonia Carosi, Claudia Bonomo, Paola Di Bonito, Aldo Venuti and Luisa Accardi

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:37

    Content type: Research

    Published on:

  4. Head and neck squamous cell carcinoma (HNSCC) is one of the main malignant tumours affecting human health, mainly due to delayed diagnosis and high invasiveness. Extracellular vehicles (EVs) are membranous ves...

    Authors: Xueying Wang, Junnan Guo, Pingyang Yu, Lunhua Guo, Xionghui Mao, Junrong Wang, Susheng Miao and Ji Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:35

    Content type: Review

    Published on:

  5. BRAFV600E mutation is the most common mutation in thyroid cancer. It strongly activates MAPK/ERK pathway and indicates an invasive subtype of thyroid cancer. PLX4032 is a selective oral inhibitor of the BRAFV6...

    Authors: Xi Su, Peng Li, Bin Han, Hao Jia, Qingzhuang Liang, Haichao Wang, Mengwei Gu, Jiaxuan Cai, Shaolei Li, Yaqi Zhou, Xin Yi and Wei Wei

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:34

    Content type: Research

    Published on:

  6. Despite the improvement of relapse-free survival mediated by anti-angiogenic drugs like sunitinib (Sutent®), or by combinations of anti-angiogenic drugs with immunotherapy, metastatic clear cell Renal Cell Car...

    Authors: Aurore Dumond, Etienne Brachet, Jérôme Durivault, Valérie Vial, Anna K. Puszko, Yves Lepelletier, Christopher Montemagno, Marina Pagnuzzi-Boncompagni, Olivier Hermine, Christiane Garbay, Nathalie Lagarde, Matthieu Montes, Luc Demange, Renaud Grépin and Gilles Pagès

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:33

    Content type: Research

    Published on:

  7. The receptor encoded by the MET oncogene and its ligand Hepatocyte Growth Factor (HGF) are at the core of the invasive-metastatic behavior. In a number of instances genetic alterations result in ligand-indepen...

    Authors: Chiara Modica, Cristina Basilico, Cristina Chiriaco, Nicla Borrelli, Paolo M. Comoglio and Elisa Vigna

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:32

    Content type: Research

    Published on:

  8. MicroRNAs (miRNAs) are abundant in tumor-derived extracellular vesicles (EVs) and the functions of extracellular miRNA to recipient cells have been extensively studied with tumorigenesis. However, the role of ...

    Authors: You Dong Liu, Xiao Peng Zhuang, Dong Lan Cai, Can Cao, Qi Sheng Gu, Xue Ni Liu, Bin Bin Zheng, Bing Jie Guan, Liang Yu, Ji Kun Li, Hui Bin Ding and Dong Wang Yan

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:31

    Content type: Research

    Published on:

  9. Anti-angiogenic therapy has been widely applied to the clinical treatment of malignant tumors. However, the efficacy of such treatments has been called into question, especially in triple-negative breast cance...

    Authors: Wei Xie, Huijie Zhao, Fengxian Wang, Yiyun Wang, Yuan He, Tong Wang, Kunchi Zhang, Hao Yang, Zhaoli Zhou, Haibin Shi, Jin Wang and Gang Huang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:30

    Content type: Research

    Published on:

  10. Circular RNAs (circRNAs), a novel class of endogenous RNAs, have shown to participate in the development of breast cancer (BC). Hsa_circ_0005273 is a circRNA generated from several exons of PTK2. However, the ...

    Authors: Xuehui Wang, Changle Ji, Jiashu Hu, Xiaochong Deng, Wenfang Zheng, Yunhe Yu, Kaiyao Hua, Xiqian Zhou and Lin Fang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:29

    Content type: Research

    Published on:

  11. Solid tumors often grow in a micro-environment characterized by < 2% O2 tension. This condition, together with the aberrant activation of specific oncogenic patwhays, increases the amount and activity of the hypo...

    Authors: Muhlis Akman, Dimas Carolina Belisario, Iris Chiara Salaroglio, Joanna Kopecka, Massimo Donadelli, Enrico De Smaele and Chiara Riganti

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:28

    Content type: Review

    Published on:

  12. The rational making the G protein-coupled receptors (GPCR) the centerpiece of targeted therapies is fueled by the awareness that GPCR-initiated signaling acts as pivotal driver of the early stages of progressi...

    Authors: Piera Tocci, Giovanni Blandino and Anna Bagnato

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:27

    Content type: Review

    Published on:

  13. Increasing evidence has demonstrated that long noncoding RNAs (lncRNAs) have regulatory functions in hepatocellular carcinoma (HCC). The link between lincSCRG1 and HCC remains unclear.

    Authors: Jun-Jie Hu, Cui Zhou, Xin Luo, Sheng-Zheng Luo, Zheng-Hong Li, Zi-Xin Xu and Ming-Yi Xu

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:26

    Content type: Research

    Published on:

  14. Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant diseases because of its non-symptomatic tumorigenesis. We previous found heat shock factor 1 (HSF1) was critical for PDAC progression and th...

    Authors: Weikun Qian, Ke Chen, Tao Qin, Ying Xiao, Jie Li, Yangyang Yue, Cancan Zhou, Jiguang Ma, Wanxing Duan, Jianjun Lei, Liang Han, Li Li, Xin Shen, Zheng Wu, Qingyong Ma and Zheng Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:25

    Content type: Research

    Published on:

  15. With the success of immune checkpoint inhibitors (ICIs), significant progress has been made in the field of cancer immunotherapy. Despite the long-lasting outcomes in responders, the majority of patients with ...

    Authors: Bin Wang, Qin Zhao, Yuyu Zhang, Zijing Liu, Zhuangzhuang Zheng, Shiyu Liu, Lingbin Meng, Ying Xin and Xin Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:24

    Content type: Review

    Published on:

  16. Alpha actinins (ACTNs) are major cytoskeletal proteins and exhibit many non-muscle functions. Emerging evidence have uncovered the regulatory role of ACTNs in tumorigenesis, however, the expression pattern, bi...

    Authors: Qian Chen, Xiao-Wei Zhou, Ai-Jun Zhang and Kang He

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:23

    Content type: Research

    Published on:

  17. The programmed cell death-1 (PD-1) receptor and its ligands PD-L1 and PD-L2 are immune checkpoints that suppress anti-cancer immunity. Typically, cancer cells express the PD-Ls that bind PD-1 on immune cells, ...

    Authors: Federica Liotti, Narender Kumar, Nella Prevete, Maria Marotta, Daniela Sorriento, Caterina Ieranò, Andrea Ronchi, Federica Zito Marino, Sonia Moretti, Renato Colella, Efiso Puxeddu, Simona Paladino, Yoshihito Kano, Michael Ohh, Stefania Scala and Rosa Marina Melillo

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:22

    Content type: Research

    Published on:

  18. Angiopoietin-like protein 1 (ANGPTL1) has been proved to suppress tumor metastasis in several cancers. However, its extracellular effects on the pre-metastatic niches (PMNs) are still unclear. ANGPTL1 has been...

    Authors: Kai Jiang, Haiyan Chen, Yimin Fang, Liubo Chen, Chenhan Zhong, Tongtong Bu, Siqi Dai, Xiang Pan, Dongliang Fu, Yucheng Qian, Jingsun Wei and Kefeng Ding

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:21

    Content type: Research

    Published on:

  19. Glioma stem cells (GSCs) are considered the initial cells of gliomas, contributing to therapeutic resistance. Patient-derived GSCs well recapitulate the heterogeneity of their parent glioma tissues, which can ...

    Authors: Zihang Chen, Huizhi Wang, Zongpu Zhang, Jianye Xu, Yanhua Qi, Hao Xue, Zijie Gao, Rongrong Zhao, Shaobo Wang, Shouji Zhang, Wei Qiu, Xing Guo and Gang Li

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:20

    Content type: Research

    Published on:

  20. Endocrine therapies with SERMs (selective estrogen receptor modulators) or SERDs (selective estrogen receptor downregulators) are standard therapies for patients with estrogen receptor (ER)-positive breast can...

    Authors: Huanhuan Huang, Jun Zhou, Hailong Chen, Jiaxin Li, Chao Zhang, Xia Jiang and Chao Ni

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:19

    Content type: Review

    Published on:

  21. Alcohol-induced intestinal dysbiosis disrupts and inflammatory responses are essential in the development of alcoholic fatty liver disease (AFLD). Here, we investigated the effects of Fmo5 on changes in enteri...

    Authors: Lingjian Kong, Jing Chen, Xiaoli Ji, Qian Qin, Huiyu Yang, Dan Liu, Deliang Li and Meiling Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:18

    Content type: Research

    Published on:

  22. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Dong Yang, Tianyang Xu, Lin Fan, Kaiyuan Liu and Guodong Li

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:17

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:201

  23. Exosomes are membrane-bound extracellular vesicles of 40–150 nm in size, that are produced by many cell types, and play an important role in the maintenance of cellular homeostasis. Exosome secretion allows fo...

    Authors: Xiangdong Xu, Yang Liu, Yan Li, Huajian Chen, Yuxuan Zhang, Jie Liu, Shaokang Deng, Yaofeng Zheng, Xinlin Sun, Jihui Wang, Taoliang Chen, Min Huang and Yiquan Ke

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:16

    Content type: Research

    Published on:

  24. Despite the advancements in new therapies for colorectal cancer (CRC), chemotherapy still constitutes the mainstay of the medical treatment. For this reason, new strategies to increase the efficacy of chemothe...

    Authors: Pietro Paolo Vitiello, Giulia Martini, Luigi Mele, Emilio Francesco Giunta, Vincenzo De Falco, Davide Ciardiello, Valentina Belli, Claudia Cardone, Nunzia Matrone, Luca Poliero, Virginia Tirino, Stefania Napolitano, Carminia Della Corte, Francesco Selvaggi, Gianpaolo Papaccio, Teresa Troiani…

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:15

    Content type: Research

    Published on:

  25. Cancer-associated fibroblasts (CAFs), the primary component of tumor stroma in tumor microenvironments, are well-known contributors to the malignant progression of gallbladder cancer (GBC). Thrombospondins (TH...

    Authors: Yu Shi, Liankang Sun, Rui Zhang, Yuan Hu, Yinying Wu, Xuyuan Dong, Danfeng Dong, Chen Chen, Zhimin Geng, Enxiao Li and Yangwei Fan

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:14

    Content type: Research

    Published on:

  26. Tumour-associated macrophages (TAMs) in the tumour microenvironment (TME) can promote the progression of hepatocellular carcinoma (HCC). Some tumours can be suppressed by targeting Wnt2b in tumour cells. Howev...

    Authors: Yu Jiang, Qiuju Han, Huajun Zhao and Jian Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:13

    Content type: Research

    Published on:

  27. Accumulating evidence has demonstrated that long non-coding RNAs (lncRNAs) are involved in the hypoxia-related cancer process and play pivotal roles in enabling malignant cells to survive under hypoxic stress....

    Authors: Jianyong Sun, Yanlu Xiong, Kuo Jiang, Bo Xin, Tongtong Jiang, Renji Wei, Yuankang Zou, Hong Tan, Tao Jiang, Angang Yang, Lintao Jia and Lei Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:12

    Content type: Research

    Published on:

  28. AS (alternative splicing) is a fundamental process by which a gene can generate multiple distinct mRNA transcripts to increase protein diversity. Defects in AS influence the occurrence and development of many ...

    Authors: Yunze Liu, Xin Liu, Changwei Lin, Xianhong Jia, Hongmei Zhu, Jun Song and Yi Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:11

    Content type: Review

    Published on:

  29. The low extracellular pH (pHe) of tumors resulting from glycolytic metabolism is a stress factor for the cells independent from concomitant hypoxia. The aim of the study was to analyze the impact of acidic pHe on...

    Authors: Mandy Rauschner, Luisa Lange, Thea Hüsing, Sarah Reime, Alexander Nolze, Marcel Maschek, Oliver Thews and Anne Riemann

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:10

    Content type: Research

    Published on:

  30. Long non-coding RNAs (lncRNAs) play vital roles in the development and progression of non-small-cell lung cancer (NSCLC); however, the role of most lncRNAs in NSCLC remains unknown. This study explored the cli...

    Authors: Rui-Qi Wang, Xiao-Ran Long, Ning-Ning Zhou, Dong-Ni Chen, Mei-Yin Zhang, Zhe-Sheng Wen, Lan-Jun Zhang, Fa-Zhong He, Zhi-Lin Zhou, Shi-Juan Mai and Hui-Yun Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:9

    Content type: Research

    Published on:

  31. Pancreatic ductal adenocarcinoma (PDAC) is an extremely lethal malignancy, with an average 5-year survival rate of 9% (Siegel RL, Miller KD, Jemal A. Ca Cancer J Clin. 2019;69(1):7-34). The steady increase in ...

    Authors: Yiqi Yu, Gang Yang, Hua Huang, Ziyao Fu, Zhe Cao, Lianfang Zheng, Lei You and Taiping Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:8

    Content type: Review

    Published on:

  32. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Liying Ma, Xing Bian and Wenchu Lin

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:7

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:219

  33. Gastric cancer (GC) is one of the most common malignant tumors worldwide. Currently, the overall survival rate of GC is still unsatisfactory despite progress in diagnosis and treatment. Therefore, studying the...

    Authors: Jiacheng Cao, Xing Zhang, Penghui Xu, Haixiao Wang, Sen Wang, Lu Zhang, Zheng Li, Li Xie, Guangli Sun, Yiwen Xia, Jialun Lv, Jing Yang and Zekuan Xu

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:6

    Content type: Research

    Published on:

  34. Choline kinase-α (ChoKα/CHKA) overexpression and hyper-activation sustain altered choline metabolism conferring the cholinic phenotype to epithelial ovarian cancer (OC), the most lethal gynecological tumor. We pr...

    Authors: Andrea Rizzo, Alessandro Satta, Giulia Garrone, Adalberto Cavalleri, Alessandra Napoli, Francesco Raspagliesi, Mariangela Figini, Loris De Cecco, Egidio Iorio, Antonella Tomassetti, Delia Mezzanzanica and Marina Bagnoli

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:5

    Content type: Research

    Published on:

  35. Progranulin (PGRN), as a multifunctional growth factor, is overexpressed in multiple tumors, but the role of PGRN on tumor immunity is still unclear. Here, we studied the effect of PGRN on breast cancer tumor ...

    Authors: Wenli Fang, Ting Zhou, He Shi, Mengli Yao, Dian Zhang, Husun Qian, Qian Zeng, Yange Wang, Fangfang Jin, Chengsen Chai and Tingmei Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:4

    Content type: Research

    Published on:

  36. Early studies indicated that ASC-J9®, an androgen receptor (AR) degradation enhancer, could suppress the prostate cancer (PCa) progression. Here we found ASC-J9® could also suppress the PCa progression via an ...

    Authors: Hao Tian, Fu-ju Chou, Jing Tian, Yong Zhang, Bosen You, Chi-Ping Huang, Shuyuan Yeh, Yuanjie Niu and Chawnshang Chang

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:3

    Content type: Research

    Published on:

  37. Both E2F transcription factor and cyclin-dependent kinases (CDKs), which increase or decrease E2F activity by phosphorylating E2F or its partner, are involved in the control of cell proliferation, and some cir...

    Authors: Jin-Chun Qi, Zhan Yang, Tao Lin, Long Ma, Ya-Xuan Wang, Yong Zhang, Chun-Cheng Gao, Kai-Long Liu, Wei Li, An-Ning Zhao, Bei Shi, Hong Zhang, Dan-Dan Wang, Xiao-Lu Wang, Jin-Kun Wen and Chang-Bao Qu

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:2

    Content type: Research

    Published on:

  38. Hepatitis B virus (HBV) infection is a crucial risk factor for hepatocellular carcinoma (HCC). However, its underlying mechanism remains understudied.

    Authors: Wenbiao Chen, Jingjing Jiang, Lan Gong, Zheyue Shu, Dairong Xiang, Xujun Zhang, Kefan Bi and Hongyan Diao

    Citation: Journal of Experimental & Clinical Cancer Research 2021 40:1

    Content type: Research

    Published on:

  39. Nerve-cancer interactions are increasingly recognized to be of paramount importance for the emergence and progression of pancreatic cancer (PCa). Here, we investigated the role of indirect cholinergic activation ...

    Authors: Paulo L. Pfitzinger, Laura Fangmann, Kun Wang, Elke Demir, Engin Gürlevik, Bettina Fleischmann-Mundt, Jennifer Brooks, Jan G. D’Haese, Steffen Teller, Andreas Hecker, Moritz Jesinghaus, Carsten Jäger, Lei Ren, Rouzanna Istvanffy, Florian Kühnel, Helmut Friess…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:289

    Content type: Research

    Published on:

  40. Growing evidence supports the pivotal role of long non-coding RNAs (lncRNAs) in the regulation of cancer development and progression. Their expression patterns and biological function in muscle invasive bladde...

    Authors: Sheng Wu, Katja Nitschke, Thomas Stefan Worst, Alexander Fierek, Cleo-Aron Weis, Markus Eckstein, Stefan Porubsky, Maximilian Kriegmair and Philipp Erben

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:288

    Content type: Research

    Published on:

  41. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Cristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, Roxana Cojocneanu, Laura-Ancuta Pop, Alin Moldovan, Cristian Moldovan, Alina Andreea Zimta, Lajos Raduly, Cecilia Pop-Bica, Mihail Buse, Liviuta Budisan, Piroska Virag, Alexandru Irimie, Sandra Martha Gomes Dias, Ioana Berindan-Neagoe…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:287

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:241

  42. Increasing evidence has revealed the close link between mitochondrial dynamic dysfunction and cancer. MIEF2 (mitochondrial elongation factor 2) is mitochondrial outer membrane protein that functions in the reg...

    Authors: Shuhua Zhao, Xiaohong Zhang, Yuan Shi, Lu Cheng, Tingting Song, Bing Wu, Jia Li and Hong Yang

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:286

    Content type: Research

    Published on:

  43. Colorectal cancer (CRC) harboring BRAFV600E mutation exhibits low response to conventional therapy and poorest prognosis. Due to the emerging correlation between gut microbiota and CRC carcinogenesis, we investig...

    Authors: Nadia Trivieri, Riccardo Pracella, Maria Grazia Cariglia, Concetta Panebianco, Paola Parrella, Alberto Visioli, Fabrizio Giani, Amata Amy Soriano, Chiara Barile, Giuseppe Canistro, Tiziana Pia Latiano, Lucia Dimitri, Francesca Bazzocchi, Dario Cassano, Angelo L. Vescovi, Valerio Pazienza…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:285

    Content type: Research

    Published on:

  44. The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-r...

    Authors: Xiao-Hui Jia, Lu-Ying Geng, Pan-Pan Jiang, Hong Xu, Ke-Jun Nan, Yu Yao, Li-Li Jiang, Hong Sun, Tian-Jie Qin and Hui Guo

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:284

    Content type: Review

    Published on:

  45. Circular RNAs (circRNAs), important members of the noncoding RNA family, have been recently revealed to play a role in the pathogenic progression of diseases, particularly in the malignant progression of cance...

    Authors: Hanchen Xu, Yujing Liu, Peiqiu Cheng, Chunyan Wang, Yang Liu, Wenjun Zhou, Yangxian Xu and Guang Ji

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:283

    Content type: Research

    Published on:

  46. Androgen deprivation therapy (ADT) is the backbone of therapy for advanced prostate cancer (PCa). Despite the good initial response, castration resistance and metastatic progression will inevitably occur. Canc...

    Authors: Yu Zhang, Jing Zhao, Mao Ding, Yiming Su, Di Cui, Chenyi Jiang, Sheng Zhao, Gaozhen Jia, Xiaohai Wang, Yuan Ruan, Yifeng Jing, Shujie Xia and Bangmin Han

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:282

    Content type: Research

    Published on:

  47. Circular RNAs (circRNAs) have been reported to play key roles in the development of various cancers. However, the biological functions and clinical significance of most circRNAs are still elusive. The purpose ...

    Authors: Yanan Zhang, Lu Zhao, Shizhou Yang, Yixuan Cen, Tingjia Zhu, Lingfang Wang, Lili Xia, Yuwan Liu, Jian Zou, Junfen Xu, Yang Li, Xiaodong Cheng, Weiguo Lu, Xinyu Wang and Xing Xie

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:281

    Content type: Research

    Published on:

  48. Accumulating evidences have shown that circular RNAs (circRNAs) play important roles in regulating the pathogenesis of cancer. However, the role of circRNAs in gastric cancer (GC) remains largely unclear.

    Authors: Qiuling Niu, Zhijie Dong, Min Liang, Yuanwei Luo, Hai Lin, Mingzhen Lin, Xiu Zhong, Wenxia Yao, Jinsheng Weng and Xinke Zhou

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:280

    Content type: Research

    Published on:

  49. HER2-targeting agents have dramatically changed the therapeutic landscape of HER2+ advanced breast cancer (ABC). Within a short time frame, the rapid introduction of new therapeutics has led to the approval of...

    Authors: Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali…

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:279

    Content type: Research

    Published on:

  50. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Fei Teng, Ju-Xiang Zhang, Qi-Meng Chang, Xu-Bo Wu, Wei-Guo Tang, Jian-Fa Wang, Jin-Feng Feng, Zi-Ping Zhang and Zhi-Qiu Hu

    Citation: Journal of Experimental & Clinical Cancer Research 2020 39:277

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:235

Annual Journal Metrics